Ophthalmology Drug Development Pipeline Review 2016: Which Companies are the Most Active? – Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Ophthalmology Drug Development Pipeline Review, 2016" report to their offering. The report provides comprehensive information on the pipeline development landscape for glaucoma, age-related macular degeneration, diabetic retinopathy, diabetic macular edema and keratoconjunctivitis sicca (dry eye), from Discovery through to the Pre-Registration stage. This includes an analysis of products by stage of development, mo

Full Story →